Vials and syringe in front of an AstraZeneca logo. (Image: John Beckmann / BSR Agency / Getty Images)
Europeans refuse the AstraZeneca vaccine, threatening the EU exit from the pandemic. The problem erupted last week, but it is taking months. sure, and EU leaders are working to repair the damage. more stories.
“There is currently an acceptance problem with the AstraZeneca vaccine,” German Chancellor Angela Merkel said last week. She put it lightly.
Merkel’s interview with the Frankfurter Allgemeine Zeitung came as governments across Europe realized that public mistrust of this particular vaccine was putting the entire vaccine campaign in jeopardy. continent.
EU official data showed that as of Wednesday, only 28% of the 7.3 million doses of the vaccine had been put into people’s arms, a massive underutilization of a precious resource.
Vaccination centers were almost empty and national leaders struggled to build confidence in the vaccine as some Europeans went out of their way to get the vaccine injected. alternatives.
AstraZeneca’s shot should have had the upper hand. It is the cheapest and easiest to store of all currently approved vaccines, and can be produced in large quantities. The company is committed to producing it at cost price for low- and middle-income countries in perpetuity. The…
News Highlights Politics
- Headline: How AstraZeneca’s vaccine got mired in politics and mistrust to become Europe’s least preferred vaccine
- Check all news and articles from the Politics news updates.